{
  "abstract": "Introduction Patients with inflammatory bowel disease (IBD) have an increased risk of colorectal cancer (CRC), and ­colonoscopic surveillance is recommended to detect and ­manage colitis-associated dysplasia or early-stage CRC. However, uptake of surveillance is variable (East et al., 2025), and patient experience and acceptability are poorly understood (Buisson et al., 2017). This review aimed to examine how adults with IBD experience colonoscopic surveillance and to identify factors influencing engagement.Methods A mixed-Methods systematic review was conducted using a convergent segregated design in accordance with the Joanna Briggs Institute methodology. Quantitative and qualitative studies exploring patient experience of colonoscopic surveillance in IBD were eligible for inclusion. Data were extracted using a standardised tool, and methodological quality was assessed using Critical Appraisal Skills Programme checklists. Quantitative findings were synthesised descriptively, qualitative findings underwent thematic synthesis, and quantitative and qualitative results were integrated during the final synthesis.Results Three studies met the inclusion criteria, including two cross-sectional questionnaire-based studies and one qualitative interview study, conducted in the UK (n=1) and the USA (n=2). Barriers to surveillance spanned five themes: bowel preparation difficulties, limited understanding of the purpose of surveillance, poor clinician communication, emotional responses such as anxiety, and practical or logistical constraints, with convergence of qualitative and quantitative findings across studies. Factors supporting engagement included clear explanations from clinicians, reassurance regarding disease status, and confidence in the benefits of surveillance.Conclusions This review provides insight into how patients with IBD experience and interpret the colonoscopic surveillance process, highlighting modifiable factors that could enhance engagement. Measures to remove barriers may improve the patient experience and thereby increase the uptake of surveillance to mitigate CRC risk. The limited available evidence highlights the need for further high-quality research in this area.",
  "authors": [
    {
      "affiliations": [
        "St Mark’s Academic Institute, London, United Kingdom"
      ],
      "name": "Jennifer Murray"
    },
    {
      "affiliations": [
        "St Mark’s Academic Institute, London, United Kingdom"
      ],
      "name": "Adam Fadra"
    },
    {
      "affiliations": [
        "St Mark’s Academic Institute, London, United Kingdom",
        "Department of Metabolism, Digestion & Reproduction, Imperial College London, London, United Kingdom"
      ],
      "name": "Ravi Misra"
    },
    {
      "affiliations": [
        "Florence Nightingale Faculty of Nursing, Midwifery & Palliative Care, King’s College London, London, United Kingdom"
      ],
      "name": "Wladyslawa Czuber-Dochan"
    },
    {
      "affiliations": [
        "St Mark’s Academic Institute, London, United Kingdom",
        "Department of Metabolism, Digestion & Reproduction, Imperial College London, London, United Kingdom"
      ],
      "name": "Naila Arebi"
    }
  ],
  "title": "P259 Understanding patient experience of colonoscopic surveillance for colorectal cancer in inflammatory bowel disease: a mixed-methods systematic review",
  "uid": "77d5c88b-bdff-5457-b767-7cc1968a4385"
}